neurotransmitters
| 3 min read
Unlike in other brain regions, levels of the neurotransmitter decrease in the cerebellum when anxiety is high, suggesting a potential new drug target.
| 5 min read
After tackling toxicity and a trial halt, Elena Koundourakis and her team at Takeda are on the cusp of a first-in-class drug for people living with narcolepsy.
| 10+ min read
The cause of hyperhidrosis, an excessive sweating condition, is enigmatic, but treatment options are plentiful and growing.
Page 1 of 1 - 3 Total Items
